Ecotoxicological quantitative structure-activity relationships for pharmaceuticals

Bulletin of Environmental Contamination and Toxicology

Volumn 79, Issue 3, 2007, Pages 331-335

  Sanderson, Hans ^a   Thomsen, Marianne ^a  

^a NATIONAL ENVIRONMENTAL RESEARCH INSTITUTE   (Denmark)

Author keywords

Ecotoxicological QSAR; Modes of action; Narcosis; Pharmaceuticals

Indexed keywords

ECOTOXICOLOGICAL QSAR; MODES-OF-ACTION; NARCOSIS;

ENVIRONMENTAL IMPACT; HYDROPHOBICITY; TOXICITY;

DRUG PRODUCTS;

CARVEDILOL; DIGOXIN; GLYCERYL TRINITRATE; LOMEFLOXACIN; METFORMIN; NICOTINIC ACID; PAROXETINE; PROPRANOLOL; WARFARIN;

ANESTHESIA; AQUATIC ENVIRONMENT; ARTICLE; DRUG MECHANISM; DRUG RESEARCH; ECOTOXICITY; HYDROPHOBICITY; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ALGAE; ANIMALS; DAPHNIA; DATABASES, FACTUAL; FISHES; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; STUPOR; TOXICITY TESTS; WATER POLLUTANTS, CHEMICAL;

APIS; EQUUS ASINUS;

EID: 34548565658     PISSN: 00074861     EISSN: 14320800     Source Type: Journal    
DOI: 10.1007/s00128-007-9249-9     Document Type: Article

References (21)

1. Calabrese EJ, Staudenmayer JW, Stanek EJ III, Hoffmann GR (2006) Hormesis outperforms threshold model in national cancer institute antitumor drug screening database. Toxicol Sci 94:368-378
2. Daughton CG, Jones-Lepp TL (2001) Pharmaceuticals and personal care products in the environment. Scientific and regulatory issues. American Chemical Society, ACS symposium series; 791. ISBN 0-8412-3739-5, USA
3. Escher BI, Eggen RIL, Schreiber U, Schreiber Z, Vye E, Wisner B, Schwarzenbach RP (2002) Baseline toxicity (narcosis) of organic chemicals determined by in vitro membrane potential measurements in energy-transducing membranes. Environ Sci Technol 36:1971-1979
4. Escher BI, Bramaz N, Eggen RIL, Richter M (2005) In vitro assessment of modes of toxic action of pharmaceuticals in aquatic life. Environ Sci Technol 39:3090-3100
5. EU (2001) CSTEE. Discussion paper on environmental risk assessment of medical products for human use (non-genetically modified organisms (non-GMO) containing). CPMPpaperRAssessHumPharm12062001/D(01). Brussels, Belgium
6. Hansch C, Hoekman D, Leo A, Zhang L, Peng L (1995) The expanding role of quantitative structure-activity relationships (QSAR) in toxicology. Toxicol Lett 79:45-53
7. Jones OAH, Voulvoulis N, Lester JN (2001) Human pharmaceuticals in the aquatic environment - a review. Environ Technol 22:1383-1394
8. Jørgensen SE, Halling-Sørensen B (2000). Editorial: drugs in the environment. Chemosphere 40:691-699
9. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LR, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36:1202-1211
10. Luckenbach T, Epel D (2005) Nitromusk and polycyclic musk compounds as long-term inhibitors of cellular xenobiotic defense systems mediated by multidrug transporters. Environ Health Perspect 113:17-24
11. Martindale (2002) In: Sweetman SC (ed) Martindale, the complete drug reference, 33 edn. Pharmaceutical Press Chicago, USA, p 2483
12. McGrath JA, Parkerton TF, DiToro DM (2004) Application of the narcosis target lipid model to algal toxicity and deriving predicted-no-effect concentrations. Environ Toxicol Chem 23:2503-2517
13. NOAA (2006) Pharmaceuticals in the environment. http://www.chbr.noaa.gov/ peiar/ (accessed 1 July 2007)
14. Öberg T (2004) A QSAR for baseline toxicity: validation, domain of application, and prediction. Chem Res Toxicol 17:1630-1637
15. Ruch RJ (2002) Intercellular communication, homeostasis, and toxicology. Toxicol Sci 68:265-266
16. Russom CL, Bradbury SP, Broderius SJ, Hammersten DE, Drummond RA (1997) Predicting modes of toxic action from chemical structure: acute toxicity in the fathead minnow (Pimephales promelas). Environ Toxicol Chem 16:948-967
17. Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR (2003) Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144:383-395
18. Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, Solomon KR (2004) Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol Pharmacol 39:158-183
19. Seiler JP (2002) Pharmacodynamic activity of drugs and ecotoxicology - can the two be connected? Toxicol Lett 131:105-115
20. USEPA (2007) ECOSAR: http://www.epa.gov/opptintr/exposure/pubs/episuite. htm (accessed 1 July 2007)
21. Veith GD, Broderius SJ (1990) Rules for distinguishing toxicants that cause type I and type II narcosis syndromes. Environ Health Perspect 87:207-211